Linda Antionette Bester

Dr. Linda Antionette Bester

Biomedical Resource Unit, School of Laboratory Medicine and Medical Sciences, College of Health Sciences, University of KwaZulu-Natal, Durban 4000, South Africa
orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 July 2016 in Journal of Applied Microbiology
Verified
Journal Article
Closed access
PDF file
JSJoh Osei Sekyere
Joh Osei Sekyere
UGUsha Govinden
Usha Govinden
Linda Antionette BesterLinda Antionette Bester
Linda Antionette Bester
SESabiha Yusuf Essack
Sabiha Yusuf Essack

1 June 2015 in Antimicrobial Agents and Chemotherapy
Verified
Journal Article
Open access
PDF file
RSRosemary Swanson
Rosemary Swanson
JAJohn Adamson
John Adamson
CMChivonne Moodley
Chivonne Moodley
BNBongani Ngcobo
Bongani Ngcobo
NANicole C Ammerman
Nicole C Ammerman
DADeepak V. Almeida
Deepak V. Almeida
The antileprosy drug clofazimine has shown potential for shortening tuberculosis treatment; however, the current dosing of the drug is not evidence based, and the optimal dosing is unknown. Our objective was to conduct a preclinical evaluation of the pharmacokinetics and pharmacodynamics of clofazimine in the mouse model of tuberculosis, with the goal of providing useful information on dosing for future studies. Pharmacokinetic parameters were evaluated in infected and uninfected BALB/c mice. Pharmacodynamic parameters were evaluated in Mycobacterium tuberculosis -infected mice that were treated for 12 weeks with one of six different clofazimine dosing regimens, i.e., doses of 6.25, 12.5, and 25 mg/kg of body weight/day and 3 regimens with loading doses. Clofazimine progressively accumulated in the lungs, livers, and spleens of the mice, reaching levels of greater than 50 μg/g in all tissues by 4 weeks of administration, while serum drug levels remained low at 1 to 2 μg/ml. Elimination of clofazimine was extremely slow, and the half-life was dependent on the duration of drug administration. Clofazimine exhibited dose-dependent tissue and serum concentrations. At any dose, clofazimine did not have bactericidal activity during the first 2 weeks of administration but subsequently demonstrated potent, dose-independent bactericidal activity. The antituberculosis activity of clofazimine was dependent on neither the dose administered nor the drug concentrations in the tissues, suggesting that much lower doses could be effectively used for tuberculosis treatment.

1 August 2017 in Nanomedicine: Nanotechnology, Biology and Medicine
Verified
Journal Article
Closed access
RKRahul Kalhapure
Rahul Kalhapure
DSDhiraj R. Sikwal
Dhiraj R. Sikwal
SRSanjeev Rambharose
Sanjeev Rambharose
CMChunderika Mocktar
Chunderika Mocktar
SSSanil Singh
Sanil Singh
TGThirumala Govender
Thirumala Govender

15 September 2018 in Applied and Environmental Microbiology
Verified
Journal Article
Closed access
ASAnou M Somboro
Anou M Somboro
JSJohn Osei Sekyere
John Osei Sekyere
DADaniel Gyamfi Amoako
Daniel Gyamfi Amoako
SESabiha Yusuf Essack
Sabiha Yusuf Essack
Linda Antionette BesterLinda Antionette Bester
Linda Antionette Bester
The worldwide proliferation of life-threatening metallo-β-lactamase (MBL)-producing Gram-negative bacteria is a serious concern to public health. MBLs are compromising the therapeutic efficacies of β-lactams, particularly carbapenems, which are last-resort antibiotics indicated for various multidrug-resistant bacterial infections.

31 July 2020 in Microbial Drug Resistance
Verified
Journal Article
Closed access
JAJonathan Asante
Jonathan Asante
DADaniel Gyamfi Amoako
Daniel Gyamfi Amoako
Akebe Luther King AbiaAkebe Luther King Abia
Akebe Luther King Abia
ASAnou M Somboro
Anou M Somboro
UGUsha Govinden
Usha Govinden
SESabiha Y. Essack
Sabiha Y. Essack
Coagulase-negative staphylococci (CoNS) have engendered substantial interest in recent years as pathogenic causes of infections in both human and veterinary medicine, especially in the immunocompromised, critically ill, long-term hospitalized and in those harboring invasive medical devices such as catheters. They have been implicated in infections such as urinary tract infections, bloodstream infections, and invasive device-related infections, and are responsible for substantial economic losses in livestock production. The advancement of diagnostic techniques has increased our understanding of their molecular mechanisms of pathogenicity, even though distinguishing between innocuousness and pathogenicity is still challenging. The incidence of CoNS varied across the continent in humans and animals (mainly cattle), ranging from 6% to 68% in suspected human infections and from 3% to 61.7% in suspected animal infections, distributed across different geographic locations. Furthermore, there were varying antibiotic resistance patterns observed in CoNS isolates, with high methicillin resistance in some cases, leading to crossresistance against many antibiotics. Staphylococcus epidermidis , Staphylococcus haemolyticus , and Staphylococcus xylosus were most commonly reported in studies herein reviewed, while the enterotoxin C gene, atl E gene, ica gene, and hemolysin virulence factors were linked with enhanced pathogenicity. Advancement in identification and typing methods, including whole genome sequencing, virulence screening, and the assessment of the immune status of subjects in studies will help to thoroughly assess the true pathogenic potential of isolated CoNS species in developing countries. Careful antibiotic stewardship guidelines should be followed due to the ability of CoNS to develop multidrug resistance.

10 February 2021 in Antibiotics
Verified
Journal Article
Open access
PDF file
SAShima E. Abdalla
Shima E. Abdalla
Akebe Luther King AbiaAkebe Luther King Abia
Akebe Luther King Abia
DADaniel Gyamfi Amoako
Daniel Gyamfi Amoako
KPKeith Perrett
Keith Perrett
Linda Antionette BesterLinda Antionette Bester
Linda Antionette Bester
SESabiha Yusuf Essack
Sabiha Yusuf Essack
Antibiotic resistance profiles of Escherichia coli were investigated in an intensive pig production system in the uMgungundlovu District, South Africa, using the ‘farm-to-fork’ approach. Four hundred seventeen (417) samples were collected from pig and pig products at different points (farm, transport, and abattoir). E. coli was isolated and enumerated using the Colilert® 18/Quanti-Tray® 2000 system. Ten isolates from each Quanti-tray were selected randomly and putatively identified on eosin methylene blue agar. Real-time PCR targeting the uidA gene was used to confirm isolates to the genus level. The Kirby–Bauer disc diffusion method was used to determine the isolates’ antibiotic susceptibility profiles against 20 antibiotics. A total of 1044 confirmed E. coli isolates were obtained across the three critical points in the food chain. Resistance was observed to all the antibiotics tested with the highest and lowest rates obtained against tetracycline (88.5%) and meropenem (0.2%), respectively. Resistance was also observed to chloramphenicol (71.4%), ampicillin (71.1%), trimethoprim-sulfamethoxazole (61.3%), amoxicillin-clavulanate (43.8%), cephalexin (34.3%), azithromycin (23.9%), nalidixic acid (22.1%), cefoxitin (21.1%), ceftriaxone (18.9%), ciprofloxacin (17.3%), cefotaxime (16.9%), gentamicin (15.5%), cefepime (13.8%), ceftazidime (9.8%), amikacin (3.4%), piperacillin-tazobactam (1.2%), tigecycline (0.9%), and imipenem (0.3%). Multidrug resistance (MDR) was observed in 71.2% of the resistant isolates with an overall multiple antibiotic resistance (MAR) index of 0.25, indicating exposure to high antibiotic use environments at the farm level. A high percentage of resistance was observed to growth promoters and antibiotics approved for veterinary medicine in South Africa. Of concern was resistance to critically important antibiotics for animal and human use and the watch and reserve categories of antibiotics. This could have adverse animal and human health consequences from a food safety perspective, necessitating efficient antibiotic stewardship and guidelines to streamline antibiotic use in the food-animal production chain.